This is out Library. Please click on the article title to view the details.
submitted by: admin on 05/07/2015
Both Germany and France have taken Actos off the market because of an increased risk of getting bladder cancer. The US is taking no action. Global sales of Actos are in the vicinity of $5 billion annually. All three "glitazone" drugs for type 2 diabetes have a poor track record. Rezulin was taken off the market more than a decade ago because it caused...
submitted by: admin on 09/19/2013
Dogs play a very important role in medical research, as service dogs, and as therapy dogs. They have been shown to sniff out cancer cells from the bladder, lung, prostate, breast, and skin with accuracy as high as 97%. They can detect when glucose levels are too high or low, to recognize when blood pressure is too high, when a heart attack is happening,...
submitted by: admin on 09/22/2013
4-F doesn’t just mean an exemption from serving in the armed forces. If you’re a Female, Fat, Forty, and Flatulent, you are particularly at risk of having gallstones. Most of the time gallstones don’t cause any symptoms at all, but they can lead to pancreatitis. Dr. Len explains what gallstones are and how they relate to pancreatitis.
submitted by: admin on 10/11/2013
The Journal of the National Cancer Institute in August published an article showing that both Avandia and Actos increase bladder cancer by more than 400% compared to baseline incidence in diabetics. These drugs account for more than 20% of all drugs used to treat type 2 diabetes. Actos ranks 9th in the sales of all pharmaceutical drugs. This is remarkable...